Wells Fargo & Company Dynavax Technologies Corp Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 42,939 shares of DVAX stock, worth $498,521. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,939

Previous 39,171 9.62%

Holding current value

$498,521

Previous $547,000 2.74%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$11.7 - $14.98 $44,085 - $56,444	3,768 Added 9.62%	42,939 $532,000
Q4 2023 Feb 09, 2024	SELL	$13.09 - $14.98 $1.04 Million - $1.19 Million	-79,117 Reduced 66.89%	39,171 $547,000
Q3 2023 Nov 13, 2023	SELL	$12.64 - $14.99 $252,092 - $298,960	-19,944 Reduced 14.43%	118,288 $1.75 Million
Q2 2023 Aug 15, 2023	BUY	$9.85 - $13.17 $149,897 - $200,421	15,218 Added 12.37%	138,232 $1.79 Million
Q1 2023 May 12, 2023	BUY	$9.44 - $11.88 $1.04 Million - $1.3 Million	109,725 Added 825.68%	123,014 $1.21 Million

Q4 2022 Feb 13, 2023	SELL	$10.27 - $13.29 $64,988 - $84,099	-6,328 Reduced 32.26%	13,289 $141,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $8,559 - $15,033	-862 Reduced 4.21%	19,617 $205,000
Q2 2022 Aug 12, 2022	SELL	$7.45 - $12.83 $805,583 - $1.39 Million	-108,132 Reduced 84.08%	20,479 $258,000
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $297,765 - $440,997	-30,540 Reduced 19.19%	128,611 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $4.39 Million - $6.98 Million	-333,489 Reduced 67.69%	159,151 $2.24 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $2.97 Million - $6.42 Million	323,825 Added 191.82%	492,640 $9.46 Million
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $774,822 - $1.17 Million	106,872 Added 172.53%	168,815 $1.66 Million
Q1 2021 May 13, 2021	SELL	$4.57 - $11.18 $668,600 - $1.64 Million	-146,302 Reduced 70.25%	61,943 $609,000
Q4 2020 Feb 09, 2021	BUY	$3.73 - $5.6 $10,850 - $16,290	2,909 Added 1.42%	208,245 $926,000
Q3 2020 Nov 05, 2020	BUY	$4.32 - $11.7 $40,284 - $109,102	9,325 Added 4.76%	205,336 $887,000
Q2 2020 Aug 13, 2020	BUY	$2.94 - $9.1 $431,053 - $1.33 Million	146,617 Added 296.83%	196,011 $1.74 Million
Q1 2020 May 14, 2020	BUY	$2.27 - $6.2 $112,124 - $306,242	49,394 New	49,394 $175,000

Others Institutions Holding DVAX

# of Institutions

266

Shares Held

132M

Call Options Held

326K

Put Options Held

758K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.47B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Dynavax Technologies Corp Transaction History